HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Susan O'Brien Selected Research

B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)

1/2022Characterization of low-grade arthralgia, myalgia, and musculoskeletal pain with ibrutinib therapy: pooled analysis of clinical trials in patients with chronic lymphocytic leukemia and mantle cell lymphoma.
12/2021Ibrutinib, fludarabine, cyclophosphamide, and obinutuzumab (iFCG) regimen for chronic lymphocytic leukemia (CLL) with mutated IGHV and without TP53 aberrations.
11/2021Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia: Results of the First Randomized Phase III Trial.
1/2021Acalabrutinib in treatment-naive chronic lymphocytic leukemia.
12/2020Risk factors for grade 3/4 transaminase elevation in patients with chronic lymphocytic leukemia treated with idelalisib.
10/2020Ibrutinib restores immune cell numbers and function in first-line and relapsed/refractory chronic lymphocytic leukemia.
1/2020Ibrutinib Treatment for First-Line and Relapsed/Refractory Chronic Lymphocytic Leukemia: Final Analysis of the Pivotal Phase Ib/II PCYC-1102 Study.
1/2020Acalabrutinib monotherapy in patients with relapsed/refractory chronic lymphocytic leukemia: updated phase 2 results.
1/2020Mechanisms of ibrutinib resistance in chronic lymphocytic leukemia and alternative treatment strategies.
12/2019Final analysis from RESONATE: Up to six years of follow-up on ibrutinib in patients with previously treated chronic lymphocytic leukemia or small lymphocytic lymphoma.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Susan O'Brien Research Topics

Disease

129B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2022 - 02/2002
123BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2020 - 03/2002
78Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2021 - 01/2002
63Philadelphia Chromosome
01/2021 - 04/2002
61Neoplasms (Cancer)
01/2022 - 02/2002
55Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
09/2017 - 01/2002
46Leukemia
01/2018 - 03/2002
40Myelodysplastic Syndromes (Myelodysplastic Syndrome)
06/2015 - 01/2002
20Infections
11/2021 - 01/2002
18Residual Neoplasm
01/2020 - 01/2003
17Blast Crisis (Blast Phase)
01/2020 - 05/2002
16Lymphoma (Lymphomas)
01/2019 - 02/2002
16Hematologic Neoplasms (Hematological Malignancy)
11/2018 - 01/2002
15Disease Progression
01/2022 - 06/2005
14Diarrhea
01/2019 - 08/2002
12Acute Promyelocytic Leukemia
01/2017 - 06/2002
10Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2022 - 02/2002
10Anemia
01/2018 - 03/2002
9Lymphocytosis
01/2020 - 09/2006
9Primary Myelofibrosis (Myelosclerosis)
02/2017 - 09/2002
9Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
04/2014 - 06/2003
8Hypertension (High Blood Pressure)
12/2019 - 11/2015
8Thrombocytopenia (Thrombopenia)
01/2019 - 09/2002
8Pathologic Complete Response
12/2018 - 06/2002
8Neutropenia
11/2018 - 06/2003
8Chromosome Aberrations (Chromosome Abnormalities)
07/2014 - 08/2002
7Atrial Fibrillation
11/2021 - 01/2016
7Nausea
09/2018 - 12/2003
7Cytopenia
03/2017 - 11/2007
6Non-Hodgkin Lymphoma (Lymphosarcoma)
11/2019 - 01/2014
6Hemorrhage
12/2018 - 06/2009
6Fatigue
12/2018 - 06/2003
6B-Cell Lymphoma (Lymphoma, B Cell)
11/2016 - 02/2002
6Splenomegaly
10/2011 - 03/2002
5Exanthema (Rash)
01/2020 - 06/2009
5Second Primary Neoplasms (Neoplasms, Second)
05/2019 - 03/2007
5Leukocytosis (Pleocytosis)
01/2017 - 12/2003
5Trisomy (Trisomies)
07/2015 - 08/2002
5Burkitt Lymphoma (Burkitt's Lymphoma)
06/2015 - 03/2002
5Lymphadenopathy
12/2014 - 01/2004
5Hairy Cell Leukemia
10/2011 - 09/2002
5Myeloproliferative Disorders (Myeloproliferative Disorder)
06/2008 - 09/2002
4Pneumonia (Pneumonitis)
01/2019 - 01/2016
4Hyperglycemia
01/2019 - 09/2006

Drug/Important Bio-Agent (IBA)

88Imatinib Mesylate (Gleevec)FDA Link
01/2018 - 05/2002
48ibrutinibIBA
01/2022 - 02/2012
48Tyrosine Kinase InhibitorsIBA
01/2021 - 09/2003
42Rituximab (Mabthera)FDA Link
12/2021 - 02/2002
35Cytarabine (Cytosar-U)FDA LinkGeneric
04/2018 - 03/2002
33fludarabineIBA
12/2021 - 10/2002
32Monoclonal AntibodiesIBA
11/2019 - 02/2002
28Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2021 - 01/2002
23Agammaglobulinaemia Tyrosine KinaseIBA
01/2022 - 02/2012
23Dasatinib (BMS 354825)FDA Link
01/2020 - 06/2006
18Proteins (Proteins, Gene)FDA Link
11/2019 - 03/2002
18Vincristine (Oncovin)FDA LinkGeneric
12/2018 - 01/2002
17Inotuzumab OzogamicinIBA
01/2021 - 06/2013
15nilotinibFDA Link
01/2020 - 06/2006
15Alemtuzumab (Campath)FDA Link
08/2011 - 05/2003
14Phosphotransferases (Kinase)IBA
06/2018 - 12/2003
14Pharmaceutical PreparationsIBA
10/2017 - 02/2002
13Dexamethasone (Maxidex)FDA LinkGeneric
05/2015 - 01/2002
13Interferon-alpha (Interferon Alfa)IBA
06/2012 - 04/2002
12InterferonsIBA
06/2012 - 06/2003
11Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric
01/2017 - 06/2002
11Doxorubicin (Adriamycin)FDA LinkGeneric
05/2015 - 01/2002
10DecitabineFDA Link
03/2015 - 08/2003
9Biological ProductsIBA
01/2018 - 08/2002
9Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2017 - 06/2002
8Transaminases (Aminotransferases)IBA
12/2020 - 04/2012
8Gemtuzumab (Mylotarg)FDA Link
01/2017 - 01/2002
8Clofarabine (Clolar)FDA Link
06/2014 - 03/2003
7BilirubinIBA
01/2020 - 04/2012
7Hemoglobins (Hemoglobin)IBA
02/2014 - 04/2002
7bcr-abl Fusion ProteinsIBA
01/2008 - 07/2002
6idelalisibIBA
12/2020 - 09/2011
6ponatinibIBA
01/2019 - 04/2015
6Arsenic Trioxide (Trisenox)FDA Link
01/2017 - 05/2003
6LigandsIBA
07/2015 - 04/2003
6Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
06/2015 - 07/2008
6NucleosidesIBA
06/2014 - 12/2003
6Messenger RNA (mRNA)IBA
12/2011 - 02/2007
6Alkylating AgentsIBA
07/2009 - 01/2004
5acalabrutinibIBA
11/2021 - 01/2016
5ofatumumabFDA Link
12/2018 - 10/2010
5HomoharringtonineIBA
01/2017 - 04/2002
5Biomarkers (Surrogate Marker)IBA
12/2015 - 02/2010
5Methotrexate (Mexate)FDA LinkGeneric
02/2015 - 03/2002
5ErythropoietinFDA Link
11/2010 - 04/2002
5L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
02/2009 - 03/2002
5TransferasesIBA
11/2007 - 03/2003
4venetoclaxIBA
01/2018 - 12/2015
4Phosphatidylinositols (Phosphatidylinositol)IBA
01/2018 - 09/2011
4Core Binding Factors (Core-Binding Factor)IBA
09/2017 - 07/2009
4Lenalidomide (CC 5013)FDA Link
01/2016 - 11/2009

Therapy/Procedure

186Therapeutics
01/2022 - 03/2002
57Drug Therapy (Chemotherapy)
01/2021 - 01/2002
14Salvage Therapy
01/2021 - 08/2005
12Stem Cell Transplantation
02/2018 - 09/2002
4Transplantation
12/2016 - 05/2007